Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a
chronic progressive or relapsing and remitting disease that usually causes weakness and …

To revise the 2010 consensus guideline on chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP). Seventeen disease experts, a patient representative, and …

Primary Sjögren syndrome (pSS) is a progressive autoimmune disease characterized by
sicca and systemic manifestations. In this Review, we summarize the available data on …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes
progressive or relapsing weakness and numbness of the limbs, which lasts for at least two …

Since the discovery of an acute monophasic paralysis, later coined Guillain–Barré
syndrome, almost 100 years ago, and the discovery of chronic, steroid-responsive …

Objective: To evaluate a trial of immunotherapy as an aid to diagnosis in suspected
autoimmune epilepsy. Method: We reviewed the charts of 110 patients seen at our …

Dysfunction of the immune system can result in damage of the peripheral nervous system.
The immunological mechanisms, which include macrophage infiltration, inflammation and …

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is probably the best
recognized progressive immune-mediated peripheral neuropathy. It is characterized by a …

Chronic neuropathies are operationally classified as primarily demyelinating or axonal, on
the basis of electrodiagnostic or pathological criteria. Demyelinating neuropathies are …